These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2057534)

  • 1. Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics.
    Nordin C; Bertilsson L; Dahl ML; Resul B; Toresson G; Sjöqvist F
    Psychopharmacology (Berl); 1991; 103(3):287-90. PubMed ID: 2057534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
    Nordin C; Bertilsson L; Siwers B
    Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10-Hydroxynortriptyline and treatment effects in elderly depressed patients.
    McCue RE; Georgotas A; Suckow RF; Cooper TB
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):176-80. PubMed ID: 2521060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nortriptyline response in elderly depressed patients.
    Kanba S; Matsumoto K; Nibuya M; Suzuki E; Kinoshita N; Shintani F; Yagi G
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 May; 16(3):301-9. PubMed ID: 1589587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients.
    Bertilsson L; Otani K; Dahl ML; Nordin C; Aberg-Wistedt A
    Pharmacol Toxicol; 1991 Feb; 68(2):100-3. PubMed ID: 1852713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-10-hydroxynortriptyline: effects and disposition of a potential novel antidepressant.
    Bertilsson L; Dahl-Puustinen ML; Nordin C
    Psychopharmacol Ser; 1989; 7():52-9. PubMed ID: 2687868
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.
    Schneider LS; Cooper TB; Severson JA; Zemplenyi T; Sloane RB
    J Clin Psychopharmacol; 1988 Dec; 8(6):402-8. PubMed ID: 3069881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.
    Nordin C; Bertilsson L
    Clin Pharmacokinet; 1995 Jan; 28(1):26-40. PubMed ID: 7712660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isomers of 10-hydroxynortriptyline in geriatric depression.
    Young RC; Dhar AK; Kutt H; Alexopoulos GS
    Ther Drug Monit; 1988; 10(2):164-7. PubMed ID: 3381232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels.
    Breyer-Pfaff U; Gaertner HJ; Kreuter F; Scharek G; Brinkschulte M; Wiatr R
    Psychopharmacology (Berl); 1982; 76(3):240-4. PubMed ID: 6808544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 10-hydroxynortriptyline in elderly depressed patients.
    Young RC; Alexopoulos GS; Shamoian CA; Manley MW; Dhar AK; Kutt H
    Clin Pharmacol Ther; 1984 Apr; 35(4):540-4. PubMed ID: 6705454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients.
    Young RC; Alexopoulos GS; Shamoian CA; Kent E; Dhar AK; Kutt H
    Am J Psychiatry; 1985 Jul; 142(7):866-8. PubMed ID: 4014510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
    Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
    J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolites.
    Malmgren R; Aberg-Wistedt A; Bertilsson L
    Psychopharmacology (Berl); 1987; 92(2):169-72. PubMed ID: 2440073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline.
    Young RC; Mattis S; Alexopoulos GS; Meyers BS; Shindledecker RD; Dhar AK
    Psychopharmacol Bull; 1991; 27(3):291-4. PubMed ID: 1775601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 10-hydroxynortriptyline and therapeutic response in geriatric depression.
    Young RC; Alexopoulos GS; Shindledecker R; Dhar AK; Kutt H
    Neuropsychopharmacology; 1988 Sep; 1(3):213-5. PubMed ID: 3251501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings.
    Dahl-Puustinen ML; Perry TL; Dumont E; von Bahr C; Nordin C; Bertilsson L
    Clin Pharmacol Ther; 1989 Jun; 45(6):650-6. PubMed ID: 2731406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite.
    Nordin C; Bertilsson L; Siwers B
    Br J Clin Pharmacol; 1985 Oct; 20(4):411-3. PubMed ID: 4074608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a therapeutic plasma level range in amitriptyline treatment of depression.
    Breyer-Pfaff U; Giedke H; Gaertner HJ; Nill K
    J Clin Psychopharmacol; 1989 Apr; 9(2):116-21. PubMed ID: 2723128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid indices and response to fluoxetine and nortriptyline in major depression.
    Gendall KA; Joyce PR; Mulder RT; Luty SE
    J Psychopharmacol; 2003 Dec; 17(4):431-7. PubMed ID: 14870956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.